3D-porous hybrid anti-inflammatory nanoscaffold for drug delivery and tissue engineering
US12350404B2 · kind B2 · utility
0Cited by
1References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 14, 2020 |
| Grant date | Jul 8, 2025 |
| Priority date | — |
| Expiry date | May 14, 2040 |
Classification
- Technology area (CPC B)Performing Operations; Transporting
- CPC primaryB82Y40/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to biodegradable nanoscaffolds, e.g. low dimension manganese oxide (MnO2)-based nanoscaffolds containing ECM proteins and/or cationic polymers, and methods of use and manufacture thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.